Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

After today's press release which was designed to notify the market that LymPro is launched except for not having the final data and not knowing which version of the test will be used I'm more confident than ever that the share price will go below .06.

I think anyone buying here thinking they're going to miss a major move higher is grossly mistaken.

Gerald blew another opportunity. To those that continually defend Gerald after each subsequent screw-up I can only say "Get A Clue"!!!